Hyperfine, Inc. (HYPR): Revenue
$13.56M
Year ended 2025-12-31
$16.54M
Trailing 12 months to 2026-06-30
+25.8%
3-year compound annual growth
+115.2%
5-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $13.56M | +5.2% | 2026-03-18, From 2025-01-01 |
| 2024-12-31 | $12.89M | +16.8% | 2026-03-18, From 2024-01-01 |
| 2023-12-31 | $11.03M | +61.9% | 2025-03-17, From 2023-01-01 |
| 2022-12-31 | $6.81M | +355.5% | 2024-03-22, From 2022-01-01 |
| 2021-12-31 | $1.50M | +408.8% | 2023-03-22, From 2021-01-01 |
| 2020-12-31 | $294.0K | n/a | 2022-03-25, From 2020-01-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| Hyperfine, Inc. (HYPR) | 2025-12-31 | $13.56M | +5.2% |
| CapsoVision, Inc (CV) | 2025-12-31 | $13.55M | +15.3% |
| Escalon Medical Corp (ESMC) | 2025-06-30 | $12.05M | +0.5% |
| QT Imaging Holdings, Inc. (QTI) | 2025-12-31 | $18.93M | +287.9% |
| Precision Optics Corporation, Inc. (POCI) | 2025-06-30 | $19.09M | -0.1% |
| Nuwellis, Inc. (NUWE) | 2025-12-31 | $8.27M | -5.4% |
| electroCore, Inc. (ECOR) | 2025-12-31 | $32.03M | +27.2% |
| Stereotaxis, Inc. (STXS) | 2025-12-31 | $32.38M | +20.3% |
| Neuraxis, Inc (NRXS) | 2025-12-31 | $3.57M | +32.9% |
Compare HYPR, CV, ESMC, QTI side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗